EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic

David Gleeson iD, Jonathan N W N Barker iD, Francesca Capon iD, Andrew E Pink iD, Richard T Woolf iD, Catherine H Smith iD, Satveer K Mahil

British Journal of Dermatology · 2023

DOI: 10.1093/bjd/ljac130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2023. Verfasst von David Gleeson und 6 weiteren Autor:innen. Beteiligte Einrichtung: St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, SE1 9RT, UK. Hauptthemen laut MEDLINE: Janus Kinase Inhibitors, Psoriasis, Exanthema. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research (NIHR), NIHR Advanced Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We carried out a critical appraisal of the literature to assess whether Janus kinase inhibitors are an effective treatment for palmoplantar pustulosis, a rare and debilitating form of psoraisis. Our appraisal identified case reports and case series of 16 patients who have been treated to good effect with tofacitinib, indicating this may be a promising therapeutic option. However, routine use of janus kinase inhibitors cannot be recommended outside the context of a clinical trial given the current low-quality of evidence available and the uncertain safety profile of Janus kinase inhibitors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase InhibitorsPsoriasisExanthemaHumansChronic DiseaseTreatment Outcome

Substanzen

Janus Kinase Inhibitors

Autor:innen und Institutionen

  • St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, SE1 9RT, UK.
  • St John's Institute of Dermatology, Faculty of Life Sciences & Medicine, King's College London, London, SE1 7EP, UK.
  • Department of Medical and Molecular Genetics, King's College London, London, SE1 9RT, UK.

ORCID-Profile: David Gleeson, Jonathan N W N Barker, Francesca Capon, Andrew E Pink, Richard T Woolf, Catherine H Smith

Förderung

  • National Institute for Health and Care Research (NIHR)
  • NIHR Advanced Fellowship

Zitieren

APA

Gleeson, D., Barker, J. N. W. N., Capon, F., Pink, A. E., Woolf, R. T., Smith, C. H., & Mahil, S. K. (2023). Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljac130

Vancouver

Gleeson D, Barker JNWN, Capon F, Pink AE, Woolf RT, Smith CH, et al. Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljac130

BibTeX
@article{Gleeson2023,
  author = {Gleeson, David and Barker, Jonathan N W N and Capon, Francesca and Pink, Andrew E and Woolf, Richard T and Smith, Catherine H and Mahil, Satveer K},
  title = {Are Janus kinase inhibitors an effective treatment for palmoplantar pustulosis? A critically appraised topic},
  journal = {British Journal of Dermatology},
  year = {2023},
  doi = {10.1093/bjd/ljac130}
}
Kostenlos starten →